Aetna is selling its Medicare Part D prescription drug unit to WellCare Health Plans; Seema Verma, administrator of CMS, defended Medicaid work requirements, saying they are not intended to kick people out of the program; an experimental tuberculosis (TB) vaccine demonstrated 54% protection in a clinical trial.
Aetna is selling its Medicare Part D prescription drug unit to WellCare Health Plans, The Wall Street Journal reported. The sale is contingent on the Justice Department approving CVS’ planned purchase of Aetna. The Justice Department was expected to ask CVS and Aetna to sell their Part D plans in order to preserve competition. CVS has the largest market share in the Medicare drug plan business, with around 6.1 million members, and Aetna is the fifth-biggest Part D seller, with around 2.2 million members. WellCare already has 1.1 million Part D enrollees and is a managed care operator focused on both Medicare and Medicaid coverage.
Seema Verma, administrator of CMS, said Medicaid work requirements are not intended to kick people out of the program, according to The Hill. “Community engagement requirements are not some subversive attempt to just kick people off of Medicaid,” Verma said in a speech in Washington, DC. “Instead, their aim is to put beneficiaries in control with the right incentives to live healthier, independent lives.” The Trump administration is preparing to defend itself against a lawsuit filed by the National Health Law Program over its approval of the Arkansas work requirements. Hearings for the case have not yet been scheduled. More than 4300 people lost their Medicaid coverage in Arkansas this month for not following the new rules.
An experimental tuberculosis (TB) vaccine demonstrated 54% protection in a clinical trial, STAT News reported. The vaccine is being developed by GSK and Aeras, a nonprofit organization working on affordable TB vaccines. The vaccine was tested in volunteers with latent tuberculosis. People who received placebo vaccine progressed from latent to active disease at roughly twice the rate of people in the trial who received the active vaccine. There is an existing TB vaccine, called bacilli Calmette-Guérin, or BCG. But studies have shown conflicting results about its effectiveness and it is not generally used in the United States. The WHO estimates that in 2017, 10 million people became ill with TB and 1.6 million people died from the disease.
The Impact of Nurse Practitioner Attribution in Medicare Shared Savings ACOs
December 5th 2023Allowing nurse practitioners to serve as attribution-eligible providers for Medicare Shared Savings Program accountable care organizations leads to no change in hierarchical condition category risk scores and modest growth in attributed beneficiaries.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology
August 1st 2023Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."
Listen
HMO and EPO Insurance Plans More Likely to Promote Use of Biosimilars
November 21st 2023Health plan type highly influences the likelihood of biosimilar uptake, with low-flexibility insurance plans more likely to have patients who either switched to a biosimilar or were initiated on a biosimilar.
Read More
What We’re Reading: UnitedHealth Lawsuit; Fentanyl Crackdown; Global Heat Deaths Increase
November 15th 2023A class action lawsuit was filed against UnitedHealth Group and a subsidiary for allegedly using an algorithm to deny rehabilitation coverage for seriously ill patients; US and China officials are finalizing an agreement to crack down on fentanyl; a study published Tuesday projected global heat deaths to increase by 370% if no action is taken against global warming.
Read More